Certificates of Analysis
| Lot ID | Peptide | Content | Lot Size | Purity | Net Content | Endotoxin | Sterility | |
|---|---|---|---|---|---|---|---|---|
| BAC0100407261 | Bacteriostatic Water | vials | ||||||
| IPA0050323261 | Ipamorelin | 5 mg | 100 vials | 99.9% | 4.7 mg (94.6%) | 11.6 EU/vial | ||
| KPV0100316261 | KPV | 10 mg | 100 vials | 99.7% | 15.1 mg (150.7 %) | 18.4 EU/vial | ||
| GHK1000316261 | GHK-Cu | 100 mg | 100 vials | 99.7 % | 95.3 mg (95.3 %) | 34 EU/vial | ||
| GHK0500316261 | GHK-Cu | 50 mg | 100 vials | 99.7 % | 47.3 mg (94.7 %) | 38.9 EU/vial | ||
| NX30100316261 | Nexia-3R | 10 MG | 100 vials | 99.7 % | 9.5 mg (95.4 %) | 19.8 EU/vial | ||
| TB50100316261 | TB-500 | 10 mg | 100 vials | 99.7 % | 11.1 mg (111.3 %) | 19.7 EU/vial | ||
| BPC0100316261 | BPC-157 | 10 mg | 100 vials | 99.5 % | 12.3 mg (122.9 %) | 17.8 EU/vial | ||
| KLO0800314261 | KLOW | 80 mg | 100 vials | 99.7 % | 86.4 mg (108.0%) | 33.3 EU/vial | ||
| ARA0100314261 | ARA-290 | 10 mg | 100 vials | 99.6 % | 9 mg (90.3 %) | 10.9 EU/vial | ||
| TES0100304261 | Tesamorelin | 10 mg | 100 vials | 99.7 % | 9.1 mg (91.2 %) | 17.8 EU/vial | ||
| CIP0100304261 | CJC/IPA | 10 mg | 100 vials | 99.9 % | 9.9 mg (98.6%) | 18.9 EU/vial | ||
Lot ID
BAC0100407261Peptide
Bacteriostatic Water
Content
Lot size
vials
Purity
Net Content
Endotoxin
Sterility
Lot ID
IPA0050323261Peptide
Ipamorelin
Content
5 mg
Lot size
100 vials
Purity
99.9%
Net Content
4.7 mg (94.6%)
Endotoxin
11.6 EU/vial
Sterility
Lot ID
KPV0100316261Peptide
KPV
Content
10 mg
Lot size
100 vials
Purity
99.7%
Net Content
15.1 mg (150.7 %)
Endotoxin
18.4 EU/vial
Sterility
Lot ID
GHK1000316261Peptide
GHK-Cu
Content
100 mg
Lot size
100 vials
Purity
99.7 %
Net Content
95.3 mg (95.3 %)
Endotoxin
34 EU/vial
Sterility
Lot ID
GHK0500316261Peptide
GHK-Cu
Content
50 mg
Lot size
100 vials
Purity
99.7 %
Net Content
47.3 mg (94.7 %)
Endotoxin
38.9 EU/vial
Sterility
Lot ID
NX30100316261Peptide
Nexia-3R
Content
10 MG
Lot size
100 vials
Purity
99.7 %
Net Content
9.5 mg (95.4 %)
Endotoxin
19.8 EU/vial
Sterility
Lot ID
TB50100316261Peptide
TB-500
Content
10 mg
Lot size
100 vials
Purity
99.7 %
Net Content
11.1 mg (111.3 %)
Endotoxin
19.7 EU/vial
Sterility
Lot ID
BPC0100316261Peptide
BPC-157
Content
10 mg
Lot size
100 vials
Purity
99.5 %
Net Content
12.3 mg (122.9 %)
Endotoxin
17.8 EU/vial
Sterility
Lot ID
KLO0800314261Peptide
KLOW
Content
80 mg
Lot size
100 vials
Purity
99.7 %
Net Content
86.4 mg (108.0%)
Endotoxin
33.3 EU/vial
Sterility
Lot ID
ARA0100314261Peptide
ARA-290
Content
10 mg
Lot size
100 vials
Purity
99.6 %
Net Content
9 mg (90.3 %)
Endotoxin
10.9 EU/vial
Sterility
Lot ID
TES0100304261Peptide
Tesamorelin
Content
10 mg
Lot size
100 vials
Purity
99.7 %
Net Content
9.1 mg (91.2 %)
Endotoxin
17.8 EU/vial
Sterility
Lot ID
CIP0100304261Peptide
CJC/IPA
Content
10 mg
Lot size
100 vials
Purity
99.9 %
Net Content
9.9 mg (98.6%)
Endotoxin
18.9 EU/vial
Sterility